BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mesa DS, Fayad MF, Arviza LP, Ruiz VDV, Carreño FC, Tamargo LA, Díaz MA, Montes SFP. Efficacy of different doses of sugammadex after continuous infusion of rocuronium. World J Clin Cases 2015; 3(4): 360-367 [PMID: 25879008 DOI: 10.12998/wjcc.v3.i4.360]
URL: https://www.wjgnet.com/2307-8960/full/v3/i4/360.htm
Number Citing Articles
Mafalda Couto, Catarina Nunes, Sérgio Vide, Pedro Amorim, Joaquim Mendes. Rocuronium Continuous Infusion for Profound Neuromuscular Blockade: A Systematic Review and Meta-analysisClinical Neuropharmacology 2019; 42(6): 203 doi: 10.1097/WNF.0000000000000366
Hwa Kyoung Lee, Junyeong Jin, Sang Il Kim, Min Jueng Kang, Eugene C. Yi, Ji Eun Kim, Jong Bae Park, Hyori Kim, Junho Chung. A point mutation in the heavy chain complementarity-determining region 3 (HCDR3) significantly enhances the specificity of an anti-ROS1 antibodyBiochemical and Biophysical Research Communications 2017; 493(1): 325 doi: 10.1016/j.bbrc.2017.09.023
I-Ying Chen, Chihiro Sugita, Yixian Wei, Nozomi Daimaruya, Takaharu Itami, Tadashi Sano, Kazuto Yamashita. Sugammadex for reversal of rocuronium-induced neuromuscular blockade during alfaxalone anesthesia in dogsVeterinary Anaesthesia and Analgesia 2023; 50(6): 485 doi: 10.1016/j.vaa.2023.08.002
Sheung-Nyoung Choi, Young-Eun Jang, Ji-Hyun Lee, Eun-Hee Kim, Jin-Tae Kim, Hee-Soo Kim. Comparison of rocuronium requirement in children with continuous infusion versus intermittent bolusEuropean Journal of Anaesthesiology 2019; 36(3): 194 doi: 10.1097/EJA.0000000000000934